This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5 mL. The contract, valued at $1,494.82, has a firm fixed price and an ultimate completion date of September 12, 2023. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $8,641.44, is for the delivery of Ciprofloxacin-Dexamethasone Otic Suspension, a pharmaceutical product used to treat certain ear infections. This is a firm fixed-price delivery order contract with a completion date of July 23, 2024. The contract does not have a set-aside designation. AmerisourceBergen, a major...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ciprofloxacin-Dexamethasone otic suspension. The contract has a ceiling value of $1,143.65 and a completion date of May 20, 2024. It is a firm fixed-price contract, without any set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ciproflox-Dexameth Otic Suspension, a medical product, with a ceiling value of $1,644.90 and a period of performance through May 7, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,369.59, is for the delivery of Ciprofloxacin-Dexamethasone Otic Suspension, a pharmaceutical product used to treat certain ear infections. The contract has a period of performance through July 12, 2024 and is a Firm Fixed Price contract type. There is no set-aside designation for this...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Ciprofloxacin-Dexamethasone otic suspension. The $1,336.80 contract has a completion date of March 12, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is the prime contractor. This delivery...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply Ciprofloxacin-Dexamethasone otic suspension (7.5 mL) for a ceiling value of $1,165.68. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential total value of $999,999,999.00 and a performance period through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,297.69 firm fixed-price delivery order is for the supply of Ciprofloxacin-Dexamethasone Otic Suspension, a pharmaceutical product used to treat ear infections. The contract has an ultimate completion date of July 12, 2024 and does not utilize a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ciproflox-Dexameth Otic Suspension, a pharmaceutical product, with a ceiling value of $1,569.12 and a period of performance through May 14, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ciprofloxacin-Dexamethasone Otic Suspension 7.5 ML, a specialty pharmaceutical product, with a ceiling value of $2,440.72. The contract has an ultimate completion date of March 8, 2024 and is a Firm Fixed Price Delivery Order. This award is not designated as a set-aside contract....